MIMEDX GROUP, INC. (MDXG)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 98,605 | 88,205 | 84,057 | 87,207 |
| Cost of sales | 18,681 | 16,558 | 15,322 | 14,855 |
| Gross profit | 79,924 | 71,647 | 68,735 | 72,352 |
| Amortization of intangible assets | 100 | 99 | 192 | 190 |
| Investigation, restatement and related | - | - | 649 | -9,701 |
| Impairment of intangible assets | - | - | 298 | - |
| Research and development | 3,303 | 3,328 | 2,918 | 3,012 |
| Selling, general and administrative | 64,151 | 59,969 | 53,516 | 55,401 |
| Operating income | 12,370 | 8,251 | 11,162 | 23,450 |
| Interest income (expense), net | 738 | 506 | 278 | 3 |
| Other expense, net | -101 | -145 | -21 | -237 |
| Income from continuing operations before income tax | 13,007 | 8,612 | 11,419 | 23,216 |
| Income tax provision | 3,389 | 1,589 | 3,541 | 5,595 |
| Net income from continuing operations | 9,618 | 7,023 | 7,878 | 17,621 |
| Income from discontinued operations, net of tax | - | - | 217 | 4 |
| Net income | 9,618 | 7,023 | 8,095 | 17,625 |
| Basic net income per common share (in dollars per share) | 0.07 | 0.05 | 0.05 | 0.12 |
| Diluted net income per common share (in dollars per share) | 0.06 | 0.05 | 0.05 | 0.12 |
| Weighted average common shares outstanding - basic (in shares) | 147,761,332 | 147,272,324 | 146,958,986 | 147,326,273 |
| Weighted average shares outstanding - diluted (in shares) | 149,317,281 | 149,677,452 | 148,373,631 | 148,897,920 |